AI Buyer Insights:

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

List of Jeeva EDC Software Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Farmacon Global Life Sciences 20 $3M United States Jeeva Clinical Trials Jeeva EDC Software Intelligent Document Processing 2022 n/a
In 2022, Farmacon Global implemented Jeeva EDC Software to enable Hispanic/Latinx and Latin America site engagement for rare-disease and other clinical trials. The deployment emphasized Intelligent Document Processing capabilities to streamline consent documentation and patient-facing materials across multi-center studies. The implementation used Jeeva EDC Software with explicit use of Jeeva eConsent and patient engagement modules, configured to support electronic case report forms and consent workflows typical of clinical research operations. Configuration work focused on multilingual consent flows and decentralized trial support, aligning electronic data capture and patient interaction features with site-level recruitment and enrollment processes. Operational scope covered clinical research operations across sites targeting Hispanic/Latinx populations in the United States and Latin America, with an implementation publicized in 2022 and estimated completed that year. Governance centered on study-level configuration of consent and engagement workflows, and reported outcomes included improved eConsent capture, enhanced patient recruitment, and strengthened decentralized trial support in the region.
Frantz Viral Therapeutics Life Sciences 10 $1M United States Jeeva Clinical Trials Jeeva EDC Software Intelligent Document Processing 2022 n/a
In 2022, Frantz Viral Therapeutics selected Jeeva EDC Software as part of Jeeva's eClinical platform to execute a multi-site Phase 2 clinical trial for HPV-associated anal HSIL. The implementation centralized eConsent and data capture across US sites and focused on Jeeva EDC Software capabilities categorized as Intelligent Document Processing. Configuration work emphasized EDC case report form design, electronic consent workflows, and CTMS study planning and site management capabilities within Jeeva EDC Software. Standard EDC activities inferred from the vendor release, such as metadata-driven CRF build, query management, role based access controls, and electronic source documentation workflows, were configured to align clinical operations with remote monitoring needs. Operational scope extended to clinical operations, site coordinators, study monitors, and regulatory oversight across participating US sites, with the platform used for enrollment tracking and centralized data aggregation. The source material does not specify external system integrations, so initial data orchestration and document processing remained within Jeeva's eClinical platform during the estimated go live. The selection and publication occurred in 2022, with an estimated go live the same year. Governance changes included updates to standard operating procedures for eConsent and site onboarding, and adjustments to monitoring and data review workflows to reflect centralized electronic capture. The deployment was undertaken to improve recruitment and study operations across US sites, leveraging Jeeva EDC Software Intelligent Document Processing capabilities for clinical data capture and consent management.
Immunoact Life Sciences 150 $8M India Jeeva Clinical Trials Jeeva EDC Software Intelligent Document Processing 2022 n/a
In 2022 Immunoact partnered with Jeeva Clinical Trials to deploy Jeeva EDC Software, using the Intelligent Document Processing application to store and share regulatory compliant clinical trial records for cell and gene therapy studies across multi center sites in India. The collaboration was publicly announced in 2022 and the deployment was estimated the same year, enabling Immunoact to avoid building a large in house IT platform while accelerating clinical development timelines. Implementation centered on core electronic data capture and study management capabilities, with inferred use of EDC and CTMS modules and likely support for eConsent and eCOA consistent with Jeeva EDC Software capabilities. The solution provided centralized regulatory compliant storage, structured document processing, and study level governance controls to support clinical operations, data management, and regulatory submissions for site networks in India. Workflows were reoriented toward centralized data capture and controlled data sharing across investigators and sponsors, with audit trail and access control features implied by regulatory compliance requirements and by the Intelligent Document Processing category.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Jeeva EDC Software

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Jeeva EDC Software. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Jeeva EDC Software Coverage

Jeeva EDC Software is a Intelligent Document Processing solution from Jeeva Clinical Trials.

Companies worldwide use Jeeva EDC Software, from small firms to large enterprises across 21+ industries.

Organizations such as Immunoact, Farmacon Global and Frantz Viral Therapeutics are recorded users of Jeeva EDC Software for Intelligent Document Processing.

Companies using Jeeva EDC Software are most concentrated in Life Sciences, with adoption spanning over 21 industries.

Companies using Jeeva EDC Software are most concentrated in India and United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Jeeva EDC Software across Americas, EMEA, and APAC.

Companies using Jeeva EDC Software range from small businesses with 0-100 employees - 66.67%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 0%.

Customers of Jeeva EDC Software include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Jeeva EDC Software customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Intelligent Document Processing.